TC BioPharm shares are trading lower after the company announced the pricing of an offering of 2 million units at $1 per unit.
Portfolio Pulse from Benzinga Newsdesk
TC BioPharm shares are trading lower after the company announced the pricing of an offering of 2 million units at $1 per unit.
August 14, 2024 | 11:56 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TC BioPharm shares are trading lower following the announcement of an offering of 2 million units at $1 per unit.
The announcement of a new offering at a price lower than the current market price typically leads to a dilution of existing shares, causing the stock price to drop.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100